Introduction
Testosterone replacement therapy (TRT) is one of the most in-demand services in men’s health and hormone optimization clinics. As a clinic owner, establishing robust, evidence-based TRT protocols is foundational to patient safety, clinical outcomes, and regulatory compliance. This article covers the essential elements of TRT clinic protocols that every practitioner-owner should understand.
Patient Selection and Eligibility
Not every patient who asks for TRT is an appropriate candidate. A thorough evaluation is essential. This includes: complete medical history (cardiovascular disease, prostate cancer, sleep apnea, fertility plans, prior hormone therapy), physical examination including testicular exam, and comprehensive laboratory evaluation. Standard lab panels for TRT initiation should include total and free testosterone, LH, FSH, estradiol, SHBG, CBC with differential, comprehensive metabolic panel, PSA (for men over 40), and thyroid function.
Absolute Contraindications to TRT
TRT is contraindicated in men with: current prostate cancer or breast cancer, untreated severe obstructive sleep apnea, polycythemia (hematocrit >54%), uncontrolled heart failure, and desire for fertility in the near future (testosterone suppresses endogenous sperm production). Men with prior cardiovascular events require careful risk-benefit analysis and shared decision-making.
TRT Delivery Methods
Multiple delivery methods are available: injectable testosterone (cypionate or enanthate, typically 100-200mg/week IM or SQ), transdermal testosterone (gels, creams, or patches), subcutaneous pellets (150-900mg every 3-6 months), and oral testosterone (testosterone undecanoate). Each method has unique pharmacokinetics, compliance profiles, and cost considerations. Discuss options with each patient and document the shared decision-making process.
Monitoring Parameters
Monitoring is critical for TRT safety and efficacy. Follow-up labs at 4-6 weeks after initiation (and after any dose change) should include total and free testosterone, estradiol, hematocrit/hemoglobin, and symptom review. After stabilization, monitoring every 3-6 months is appropriate for most patients. Annual monitoring should include PSA (for men over 40), CBC, and metabolic panel.
Managing Common Side Effects
Common TRT side effects include: erythrocytosis (elevated hematocrit), estradiol elevation (causing gynecomastia, fluid retention, or mood symptoms), testicular atrophy, and acne. Your protocol should include clear guidance on managing each. Estradiol management may involve aromatase inhibitors. Erythrocytosis may require dose reduction, more frequent phlebotomy, or switching delivery method. HCG or clomiphene can be added to preserve testicular function and fertility potential.
Documentation and Informed Consent
Thorough documentation protects both the patient and the practitioner. Each TRT patient’s chart should include: documented low testosterone with specific lab values, discussion of risks and benefits, signed informed consent, treatment plan with specific medication, dose, and frequency, and follow-up plan with labs. Never prescribe TRT without documented clinical indication and informed consent.
Conclusion
A well-designed TRT protocol is the cornerstone of a successful men’s health or hormone optimization clinic. It ensures consistent, safe, evidence-based care for every patient and protects your practice from regulatory and liability risk. Review and update your protocols annually in light of new evidence and changing clinical guidelines.